|
|
Other links at Articles > Internal Medicine |
| 2. |
International Approvals: Isentress, WinRho SDF, Cyanokit
|
|
|
Canada has approved raltegravir tablets (Isentress) and a liquid formulation of a Rho (D) intravenous immune globulin [human] product (WinRho SDF); Europe has approved a hydroxocobalamin kit (Cyanokit). Medscape Medical News
|
| 4. |
Comorbidity in Irritable Bowel Syndrome
|
|
|
Comorbid nongastrointestinal symptoms account for two-thirds of excess health-care costs in irritable bowel syndrome (IBS). Are IBS patients at greater risk for comorbidities?
The American Journal of Gastroenterology
|
|
|